OPDIVO (nivolumab) Patient Assistance Program
Don’t let the high cost of brand specialty cancer immunotherapy stand between you and the treatment you need. We help eligible patients access Opdivo (nivolumab) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Opdivo (nivolumab) is FDA-approved across many cancer types — melanoma (treatment and adjuvant), non-small cell lung cancer (neoadjuvant, first-line in combination, and after platinum-based chemotherapy), renal cell carcinoma, urothelial carcinoma, head and neck cancers, esophageal and gastric cancers, hepatocellular carcinoma, classical Hodgkin lymphoma, and several others.
- Without assistance, the cost commonly runs $6,000–$12,000 per infusion, with monthly totals ranging $12,000–$26,000 depending on regimen and dosing schedule.
- Through AffordMyPrescriptions, qualifying patients can access Opdivo coverage for a flat $69.95 per month — our advocacy team manages the entire enrollment, infusions, and renewal process
- There is no FDA-approved biosimilar to Opdivo available in the U.S. as of 2026.
What is Opdivo Prescription Assistance Program?
The Opdivo Prescription Assistance Program is a manufacturer-sponsored initiative that provides Opdivo infusions at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for cancer patients who are uninsured or underinsured, as well as Medicare Part D beneficiaries who cannot afford specialty checkpoint inhibitor therapy.
Navigating the program on your own means dealing with eligibility verification, oncology-team coordination, prior-authorization documentation, infusion scheduling, and renewal deadlines — all while managing advanced cancer treatment.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through infusion-schedule coordination and annual re-certification — so you focus on your treatment, not paperwork.
Pharmacy Price Comparison
- Without assistance, Opdivo infusions cost roughly $6,000–$12,000 each at retail/specialty pricing. Pharmacy discount coupons are not a meaningful tool for IV therapy. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| 240 mg infusion (every 2 wks) | ~$6,500.00 | Save ~$6,430/dose |
| 480 mg infusion (every 4 wks) | ~$12,000.00 | Save ~$11,930/dose |
| Combo with ipilimumab | ~$15,000+ | Save thousands/cycle |
| Monthly total (single agent) | ~$13,000 | Save ~$12,930/mo |
| Annual treatment cost | ~$150,000+ | Save ~$149,000+/yr |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Opdivo Prescription Program?
The Patient Assistance Program is free to apply for and provides Opdivo infusions at little or no medication cost if approved. But the process involves detailed applications, oncology-team coordination, prior-authorization documentation, infusion scheduling, and ongoing renewal management. Our $69.95/month service covers full advocacy: applications, doctor coordination, infusion scheduling, documentation, and annual re-enrollment — so you focus on your treatment, not paperwork.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Opdivo:
Limitations of Coupons
Prices fluctuate — savings aren’t guaranteed month-to-month
Copay accumulators may prevent savings from counting toward your deductible
Coupon cards expire and require constant renewal
Still $6,000–$12,000 per month even with the best discount
Cannot be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
Medication supplied directly through the assistance program
We manage all paperwork, refills, and annual renewals
Medicare Part D patients accepted
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Opdivo assistance.
- You are a U.S. citizen or legal resident
- You Have A Valid Opdivo Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Understanding Opdivo:
Opdivo (nivolumab) is an intravenous (IV) immunotherapy used to treat a wide range of cancers including melanoma, non-small cell lung cancer, kidney cancer, head and neck cancer, bladder cancer, esophageal and gastric cancers, classical Hodgkin lymphoma, and several others. It belongs to a class of medicines called PD-1 checkpoint inhibitors and is given by infusion in a clinic, infusion center, or hospital outpatient setting.
How It Works:
Opdivo is a monoclonal antibody that blocks a protein called PD-1 on T cells, which normally acts as an immune “off-switch.” By preventing cancer cells from using this switch to hide from the immune system, the drug allows T cells to stay active and attack tumor cells effectively. This targeted approach helps the body’s own defenses recognize and destroy cancer across various tumor types.
Form and Use:
This medication is administered through an IV infusion that typically lasts 30 minutes. Common schedules for use on its own include a dose every two weeks or a larger dose every four weeks, though these intervals may change if it is combined with other treatments like chemotherapy. Your oncology team will determine the specific regimen based on your diagnosis and treatment plan.
Generic Availability:
As of 2026, there is no FDA-approved biosimilar version of Opdivo available in the United States. While other similar checkpoint inhibitors are approved for certain cancers, they are not interchangeable generic substitutes. Any decision to use a different immunotherapy depends on your specific biomarkers and treatment history and must be made by your oncology team.
Warnings:
The most significant risks involve immune-related side effects, where the immune system may mistakenly attack healthy organs like the lungs, liver, or intestines. Patients should immediately report symptoms such as a new cough, persistent diarrhea, yellowing of the skin, or severe fatigue. Because these reactions can be serious, your medical team will monitor you closely for infusion-related complications and organ dysfunction.
FAQ (Frequently Asked Questions)
How Much Does Opdivo Cost Without Insurance?
Per-infusion cost commonly runs $6,000–$12,000, with monthly totals typically $12,000–$26,000 depending on regimen and schedule. Through AffordMyPrescriptions, qualifying patients receive Opdivo infusions at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Kinds Of Side Effects Should I Watch For?
Because Opdivo activates the immune system, the most characteristic side effects are immune-related — meaning they occur when the immune system attacks normal tissue. These can affect the lungs, intestines, liver, kidneys, skin, endocrine glands, and other organs. Tell your oncology team promptly about new cough or shortness of breath, persistent diarrhea, yellowing of the skin or eyes, dark urine, fatigue, severe skin rash, or any new symptom. Many of these are manageable when caught early.
Are There Other Checkpoint Inhibitors I Should Know About?
Yes. Other PD-1 inhibitors and PD-L1 inhibitors are FDA-approved for some of the same cancer types, and in certain situations they can be reasonable clinical alternatives. Whether one is a fit for you depends on your cancer type, prior treatments, and biomarker testing. We mention this directly because if a different therapy on a more accessible assistance pathway would work for your situation, that may be a better path.
Can I Get Opdivo Through The PAP If I Have Medicare?
Yes. Medicare beneficiaries can typically qualify for Opdivo Patient Assistance, especially if you face significant out-of-pocket costs under medical or pharmacy benefits. The manufacturer’s commercial copay assistance program ($0 per infusion for eligible patients) is reserved for commercially insured patients only — but the underlying PAP supports Medicare patients who meet income criteria.
What If My Application Is Denied?
If your initial application is denied, we explore alternative savings paths on your behalf — including independent oncology-focused foundations such as the PAN Foundation or HealthWell Foundation, disease-specific organizations like the Melanoma Research Foundation, GO2 for Lung Cancer, or the Kidney Cancer Association, the manufacturer’s copay assistance program if you have commercial insurance, or asking your oncology team whether a different checkpoint inhibitor or treatment plan would be appropriate. If we cannot find a path, you will not be charged our service fee.
How Long Does It Take To Get Approved?
Most enrolled patients see their first covered Opdivo infusion within two to four weeks of completing the documentation. Timing depends on how quickly your oncology team returns the required forms and the program processes your application.
Take Control of Your Medication Costs
If you are struggling with the high cost of Opdivo, our team may be able to help you access assistance programs designed to make brand specialty cancer immunotherapy affordable. Check your eligibility today and take the first step toward predictable, sustainable treatment.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.